Functions and mechanisms of redox regulation of cysteine-based phosphatases

Antioxidants and Redox Signaling

Volumn 7, Issue 5-6, 2005, Pages 560-577

  Salmeen, Annette ^a   Barford, David ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; CYSTEINE BASED PHOSPHATASE; GLUTATHIONE; HYDROGEN PEROXIDE; KINASE ASSOCIATED PHOSPHATASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; REACTIVE OXYGEN METABOLITE; SULFENAMIDE DERIVATIVE; SULFENIC ACID DERIVATIVE; SULFINAMIDE; SULFINIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

CATALYSIS; DISULFIDE BOND; ENZYME ACTIVITY; HUMAN; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYSTEINE; HUMANS; OXIDATION-REDUCTION; PHOSPHORIC MONOESTER HYDROLASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TYROSINE;

EID: 17644371347     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.560     Document Type: Review

References (96)

1. Alonso A, Sasin J, Bottini N, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, and Mustelin T. Protein tyrosine phosphatases in the human genome. Cell 117 699-711, 2004.
2. Andersen JN, Jansen PG, Echwald SM, Mortensen OH. Fukada T, Del Vecchio R, Tonks NK, and Moller NP. A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. FASEB J 18: 8-30, 2004.
3. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, and Rhee SG. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. J Biol Chem 272: 217-221, 1997.
4. Bandyopadhyay D, Kusari A, Kenner KA, Liu F, Chernoff J, Gustafson TA, and Kusari J. Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin. J Biol Chem 272: 1639-1645, 1997.
5. Barford D, Flint AJ, and Tonks NK. Crystal structure of human protein tyrosine phosphatase 1B. Science 263: 1397-1404, 1994.
6. Barford D, Das AK, and Egloff MP. The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 27: 133-164, 1998.
7. Barrett WC, DeGnore JP, Keng YF, Zhang ZY, Yim MB, and Chock PB. Roles of Superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B. J Biol Chem 274: 34543-34546, 1999.
8. Barrett WC, DeGnore JP, Konig S, Paies HM, Keng YF, Zhang ZY, Yim MB, and Chock PB. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38: 6699-6705, 1999.
9. Biteau B, Labarre J, and Toledano MB. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425: 980-984, 2003.
10. Blanchetot C, Tertoolen LG, and den Hertog J. Regulation of receptor protein-tyrosine phosphatase alpha by oxidative stress. EMBO J 21: 493-503, 2002.
11. Blanchetot C, Tertoolen LG, Overvoorde J, and den Hertog J. Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases. J Biol Chem 277: 47263-47269, 2002.
12. Buist A, Zhang YL, Keng YF, Wu L, Zhang ZY, and den Hertog J. Restoration of potent protein-tyrosine phosphatase activity into the membrane-distal domain of receptor protein-tyrosine phosphatase alpha. Biochemistry 38: 914-922, 1999.
13. Burridge K and Nelson A. An in-gel assay for protein tyrosine phosphatase activity: detection of widespread distribution in cells and tissues. Anal Biochem 232: 56-64, 1995.
14. 2. J Biol Chem 273: 32554-32560, 1998.
15. Chance B, Sies H, Boveris A, and Oshino N. Hydroperoxide metabolism in mammalian organs. Physiol Rev 59: 527-605, 1979.
16. Cheng G, Cao Z, Xu X, van Meir EG, and Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140, 2001.
17. Chiarugi P and Cirri P. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci 28: 509-514, 2003.
18. Chiarugi P, Fiaschi T, Taddei ML, Talini D, Giannoni E, Raugei G, and Ramponi G. Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J Biol Chem 276: 33478-33487, 2001.
19. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, Raugei G, Symons M, Borrello S, Galeotti T, and Ramponi G. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161: 933-944, 2003.
20. Claiborne A, Yeh JI, Mallett TC, Luba J, Crane EJ 3rd, Charrier V, and Parsonage D. Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry 38: 15407-15416, 1999.
21. Czech MP, Lawrence JC Jr, and Lynn WS. Evidence for the involvement of sulfhydryl oxidation in the regulation of fat cell hexose transport by insulin. Proc Natl Acad Sci U S A 71: 4173-4177, 1974.
22. Denu JM and Tanner KG. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37: 5633-5642, 1998.
23. Denu JM, Zhou G, Guo Y, and Dixon JE. The catalytic role of aspartic acid-92 in a human dual-specific protein-tyrosine-phosphatase. Biochemistry 34: 3396-3403, 1995.
24. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, and Kennedy BP. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283: 1544-1548, 1999.
25. Evans B, Tishmack PA, Pokalsky C, Zhang M, and Van Etten RL. Site-directed mutagenesis, kinetic, and spectroscopic studies of the P-loop residues in a low molecular weight protein tyrosine phosphatase. Biochemistry 35: 13609-13617, 1996.
26. Fauman EB and Saper MA. Structure and function of the protein tyrosine phosphatases. Trends Biochem Sci 21: 413-417, 1996.
27. Fauman EB, Cogswell JP, Lovejoy B, Rocque WJ, Holmes W, Montana VG, Piwnica-Worms H, Rink MJ, and Saper MA. Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25A. Cell 93: 617-625, 1998.
28. Finkel T. Redox-dependent signal transduction. FEBS Lett 476: 52-54, 2000.
29. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol 15: 247-254, 2003.
30. Haj FG, Markova B, Klaman LD, Bohmer FD, and Neel BG. Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem 278: 739-744, 2003.
31. 2 and vanadate in vitro. Biochem Biophys Res Commun 188: 773-779, 1992.
32. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem 265: 2896-2902, 1990.
33. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, and Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275: 1649-1652, 1997.
34. Jackson MD and Denu JM. Molecular reactions of protein phosphatases-insights from structure and chemistry. Chem Rev 101: 2313-2340, 2001.
35. Jia Z, Barford D, Flint AJ, and Tonks NK. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science 268: 1754-1758, 1995.
36. Kim W, Dannaldson J, and Gates KS. Reactions of 3H-1,2-benzodithiol-3-one 1-oxide with amines and anilines. Tetrahedron Lett 37: 5337-5340, 1996.
37. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, and Kahn BB. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20: 5479-5489, 2000.
38. Knebel A, Rahmsdorf HJ, Ullrich A, and Herrlich P. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J 15: 5314-5325, 1996.
39. Koshio O, Akanuma Y, and Kasuga M. Hydrogen peroxide stimulates tyrosine phosphorylation of the insulin receptor and its tyrosine kinase activity in intact cells. Biochem J 250: 95-101, 1988.
40. 2. J Biol Chem 272: 10135-10143, 1997.
41. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189, 2004.
42. Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P, and Pavletich NP. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99: 323-334, 1999.
43. Lee SR, Kwon KS, Kim SR, and Rhee SG. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273: 15366-15372, 1998.
44. 2. J Biol Chem 277: 20336-20342, 2002.
45. Leslie NR, Bennett D, Lindsay YE, Stewart H, Gray A, and Downes CP. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 22: 5501-5510, 2003.
46. Li S and Whorton AR. Regulation of protein tyrosine phosphatase 1B in intact cells by S-nitrosothiols. Arch Biochem Biophys 410: 269-279, 2003.
47. Lim KL, Lai DS, Kalousek MB, Wang Y, and Pallen CJ. Kinetic analysis of two closely related receptor-like protein-tyrosine-phosphatases, PTP alpha and PTP epsilon. Eur J Biochem 245: 693-700, 1997.
48. Lohse DL, Denu JM, Santoro N, and Dixon JE. Roles of aspartic acid-181 and serine-222 in intermediate formation and hydrolysis of the mammalian protein-tyrosine-phosphatase PTP1. Biochemistry 16: 4568-4575, 1997.
49. Maehama T and Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375-13378, 1998.
50. Mahadev K, Wu X, Zilbering A, Zhu L, Lawrence JT, and Goldstein BJ. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 276: 48662-48669, 2001.
51. Mahadev K, Zilbering A, Zhu L, and Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. J Biol Chem 276: 21938-21942, 2001.
52. 2 and plays an integral role in insulin signal transduction. Mol Cell Biol 24: 1844-1854, 2004.
53. McCain DF, Catrina IE, Hengge AC, and Zhang ZY. The catalytic mechanism of Cdc25A phosphatase. J Biol Chem 277: 11190-11200, 2002.
54. Meng TC, Fukada T, and Tonks NK. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9: 387-399, 2002.
55. Messens J, Martins JC, Van Belle K, Brosens E, Desmyter A, De Gieter M, Wieruszeski JM, Willem R, Wyns L, and Zegers I. All intermediates of the arsenate reductase mechanism, including an intramolecular dynamic disulfide cascade. Proc Natl Acad Sci U S A 99: 8506-8511, 2002.
56. Morin RB and Gordon EM. Chemistry of dehydropeptides. A rearrangement of an isothiazolone. Tetrahedron Lett 24: 2159-2162, 1973.
57. Morin RB, Gordon EM, and Lake JR. Chemistry of dehydropeptides. Formation of isothiazolones and isothiazolidones from cysteinyl peptides. Tetrahedron Lett 52: 5213-5216, 1973.
58. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigle MH, Parsons R, and Tonks NK. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A 94: 9052-9057, 1997.
59. Nam HJ, Poy F, Krueger NX, Saito H, and Frederick CA. Crystal structure of the tandem phosphatase domains of RPTP LAR. Cell 97: 449-457, 1999.
60. Nimnual AS, Taylor LJ, and Bar-Sagi D. Redox-dependent downregulation of Rho by Rac. Nat Cell Biol 5: 236-241, 2003.
61. Pani G, Colavitti R, Bedogni B, Anzevino R, Borrello S, and Galeotti TA. Redox signaling mechanism for density-dependent inhibition of cell growth. J Biol Chem 275: 38891-38899, 2000.
62. Pani G, Bedogni B, Colavitti R, Anzevino R, Borrello S, and Galeotti T. Cell compartmentalization in redox signaling. IUBMB Life 52: 7-16, 2001.
63. Pannifer AD, Flint AJ, Tonks NK, and Barford D. Visualization of the cysteinyl-phosphate intermediate of a protein-tyrosine phosphatase by X-ray crystallography. J Biol Chem 273: 10454-10462, 1998.
64. Peppelenbosch MP, Qiu RG, de Vries-Smits AM, Tertoolen LG, de Laat SW, McCormick F, Hall A, Symons MH, and Bos JL. Rac mediates growth factor-induced arachidonic acid release. Cell 81: 849-856, 1995.
65. Persson C, Sjoblom T, Groen A, Kappert K, Engstrom U, Hellman U, Heldin CH, Den Hertog J, and Ostman A. Preferential oxidation of the second phosphatase domain of receptor-like PTP-α revealed by an antibody against oxidized protein tyrosine phosphatases. Proc Natl Acad Sci U S A 101: 186-191, 2004.
66. Poon RY and Hunter T. Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science 270: 90-93, 1995.
67. Reynolds RA, Yem AW, Wolfe CL, Deibel MR Jr, Chidester CG, and Watenpaugh KD. Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle. J Mol Biol 293: 559-568, 1999.
68. Rhee SG, Bae YS, Lee S-R, and Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000: PE1, 2000.
69. Rusnak F and Reiter T. Sensing electrons: protein phosphatase redox regulation. Trends Biochem Sci 25: 527-529, 2000.
70. Salmeen A, Andersen JN, Myers MP, Tonks NK, and Barford D. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol Cell 6: 1401-1412, 2000.
71. Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, and Barford D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423: 769-773, 2003.
72. Sattler M, Winkler T, Verma S, Byrne CH, Shrikhande G, Salgia R, and Griffin JD. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 93: 2928-2935, 1999.
73. Savitsky PA and Finkel T. Redox regulation of Cdc25C. J Biol Chem 277: 20535-20540, 2002.
74. Segal AW and Shatwell KP. The NADPH oxidase of phagocytic leukocytes. Ann N Y Acad Sci 832: 215-222, 1997.
75. Sohn J and Rudolph J. Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction. Biochemistry 42: 10060-10070, 2003.
76. Song H, Hanlon N, Brown NR, Noble ME, Johnson LN, and Barford D. Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phospho-CDK2. Mol Cell 7: 615-626, 2001.
77. Su XD, Taddei N, Stefani M, Ramponi G, and Nordlund P. The crystal structure of a low-molecular-weight phosphotyrosine protein phosphatase. Nature 370: 575-578, 1994.
78. 2 on protein tyrosine phosphatase activity in HER14 cells. Free Radic Biol Med 16: 399-403, 1994.
79. 2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
80. Sundaresan M, Yu ZX, Ferrans VJ, Sulciner DJ, Gutkind JS, Irani K, Goldschmidt-Clermont PJ, and Finkel T. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem J 318: 379-382, 1996.
81. Szatrowski TP and Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798, 1991.
82. Takakura K, Beckman JS, MacMillan-Crow LA, and Crow JP. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite. Arch Biochem Biophys 369: 197-207, 1999.
83. Tao J, Malbon CC, and Wang HY. Insulin stimulates tyrosine phosphorylation and inactivation of protein-tyrosine phosphatase 1B in vivo. J Biol Chem 276: 29520-29525, 2001.
84. Tonks NK. PTP1B: from the sidelines to the front lines! FEBS Lett 546: 140-148, 2003.
85. Tonks NK and Neel BG. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr Opin Cell Biol 13: 182-195, 2001.
86. van der Wijk T, Blanchetot C, Overvoorde J, and den Hertog J. Redox-regulated rotational coupling of receptor protein-tyrosine phosphatase alpha dimers. J Biol Chem 278: 13968-13974, 2003.
87. van Montfort RL, Congreve M, Tisi D, Carr R, and Jhoti H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 423: 773-777, 2003.
88. Wang Y and Fallen CJ. The receptor-like protein tyrosine phosphatase HPTP alpha has two active catalytic domains with distinct substrate specificities. EMBO J 10: 3231-3237, 1991.
89. Werner E and Werb Z. Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. J Cell Biol 158: 357-368, 2002.
90. Woo CH, Eom YW, Yoo MH, You HJ, Han HJ, Song WK, Yoo YJ, Chun JS, and Kim JH. Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J Biol Chem 275: 32357-32362, 2000.
91. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, Kim K, and Rhee SG. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300: 653-656, 2003.
92. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 32: 488-495, 1998.
93. Zegers I, Martins JC, Willem R, Wyns L, and Messens J. Arsenate reductase from S. aureus plasmid p1258 is a phosphatase drafted for redox duty. Nat Struct Biol 8: 843-847, 2001.
94. Zhang M, Van Etten RL, and Stauffacher CV. Crystal structure of bovine heart phosphotyrosyl phosphatase at 2.2-A resolution. Biochemistry 33: 11097-11105, 1994.
95. Zhang ZY and Dixon JE. Active site labeling of the Yersinia protein tyrosine phosphatase: the determination of the pK of the active site cysteine and the function of the conserved histidine 402. Biochemistry 32: 9340-9345, 1993.
96. Zhou G, Denu JM, Wu L, and Dixon JE. The catalytic role of Cys124 in the dual specificity phosphatase VHR. J Biol Chem 269: 28084-28090, 1994.